Global Gastric Cancer Diagnostic Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Gastric Cancer Diagnostic Industry In 2025?

The gastric cancer diagnostic market has seen strong expansion in recent years. It is anticipated to increase from $2.59 billion in 2024 to $2.78 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. This growth observed in previous periods is largely attributable to the escalating prevalence of helicobacter pylori infection, enhanced awareness concerning gastric cancer symptoms, the rising occurrence of gastric cancer among older populations, increased intake of smoked and preserved foods, and the expanded application of diagnostic screening in high-risk groups.

The gastric cancer diagnostic market size is projected to experience substantial expansion over the coming years. It is anticipated to reach $3.63 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period can be attributed to several factors, including an increasing demand for early detection and screening programs, rising awareness campaigns focused on preventing gastric cancer, the growing adoption of personalized medicine approaches, the expansion of healthcare infrastructure in emerging markets, and a heightened focus on non-invasive and rapid diagnostic tests. Key trends anticipated during this period encompass technological advancements in molecular diagnostics, the development of biomarker panels to enhance diagnostic accuracy, the creation of portable diagnostic devices for point-of-care testing, the innovation of minimally invasive diagnostic tools, and the integration of various imaging modalities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27291&type=smp

Which Major Market Drivers Are Shaping The Future Of The Gastric Cancer Diagnostic Market?

The increasing occurrence of gastric cancer is anticipated to fuel the expansion of the gastric cancer diagnostic market in the coming years. Gastric cancer itself is defined as a malignant tumor originating in the stomach lining, where cells multiply uncontrollably, forming a mass that can penetrate nearby tissues and spread throughout the body. This surge in gastric cancer cases stems from unhealthy eating patterns, as consuming large quantities of salted, smoked, and processed foods heightens the damage to the stomach lining and increases cancer risk. Gastric cancer diagnostic tools contribute to its early detection by identifying malignant lesions, which is crucial for timely medical intervention and enhanced patient prognoses. These tools boost clinical effectiveness by yielding accurate and quick results, thereby supporting superior disease management. For instance, in May 2024, the American Cancer Society, a US-based nonprofit organization, reported that the count of new stomach cancer cases hit 26,890 in 2024, representing an increase from 26,500 cases in 2023. Thus, the escalating incidence of gastric cancer is a primary force driving the growth of the gastric cancer diagnostic market.

What Are The Major Segment Types Covered In The Gastric Cancer Diagnostic Market?

The gastric cancer diagnostic market covered in this report is segmented

1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing

2) By Product: Reagents And Consumables, Instruments

3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies

4) By Application: Early Diagnosis, Screening, Monitoring

5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy

2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound

3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy

4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology

5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

Which Trends Are Impacting The Gastric Cancer Diagnostic Market?

Leading companies operating within the gastric cancer diagnostic market are focusing on developing advanced diagnostic tools, including artificial intelligence-based endoscopic diagnostic support devices, to enhance early detection and accuracy. These AI-powered endoscopic diagnostic support devices are intelligent tools designed to assist in identifying and assessing gastrointestinal abnormalities during endoscopic procedures. For instance, in March 2024, AI Medical Service Inc., a medical technology company based in Japan, launched GastroAI-model G, an AI-powered endoscopic diagnostic support system. This system aids gastroenterologists during endoscopy by analyzing video images in real time to identify potential cancerous lesions. It employs deep learning techniques to detect suspicious areas indicative of early gastric cancer, which may necessitate a biopsy or further examination. When such lesions are identified, the system promptly alerts the physician by highlighting the area with a rectangle on the endoscopic screen, thereby improving diagnostic accuracy and enabling early cancer detection.

Which Key Players Are Driving Competition In The Gastric Cancer Diagnostic Market?

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-global-market-report

What Regional Growth Trends Are Shaping The Gastric Cancer Diagnostic Market Outlook?

North America was the largest region in the gastric cancer diagnostic market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastric Cancer Diagnostic Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27291&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Market 2025, By The Business Research Company

Mineral Wool Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mineral-wool-global-market-report

Thermal Insulation Material Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/thermal-insulation-material-global-market-report

Building Insulation Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795